Why Kewaunee Scientific Corporation’s (KEQU) Stock Is Up 6.21%
As of Wednesday, July 22, Kewaunee Scientific Corporation’s KEQU share price has surged by 6.21%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Stock Evaluator: Kewaunee Scientific Corporation (KEQU)
Kewaunee Scientific Corporation KEQU
$36.84
0.00
0.00%
July 30, 2026 4:00:00 PM
EST
Volume: 21
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer enclosures, biological safety cabinets, CO2 incubators, ultralow freezers, epoxy resin work surfaces and sinks, and other laboratory products. It also provides facility design, detailed engineering, construction, and project management services. The company’s laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare markets; and its technical products are used in facilities manufacturing computers and light electronics, and by users of computer and networking furniture. It sells its products through dealers, its subsidiaries, and a national stocking distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Commentary & Analysis
Why Kewaunee Scientific Corporation’s (KEQU) Stock Is Down 10.98%
As of Thursday, March 12, Kewaunee Scientific Corporation’s KEQU share price has dipped by 10.98%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Kewaunee Scientific Corporation’s (KEQU) Stock Is Down 14.03%
As of Thursday, March 12, Kewaunee Scientific Corporation’s KEQU share price has dipped by 14.03%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Kewaunee Scientific Corporation’s (KEQU) Stock Is Down 5.50%
As of Thursday, December 11, Kewaunee Scientific Corporation’s KEQU share price has dipped by 5.50%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Kewaunee Scientific Corporation’s (KEQU) Stock Is Up 5.27%
As of Monday, September 15, Kewaunee Scientific Corporation’s KEQU share price has surged by 5.27%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $106.0 | $334.8 | 22% |
|
| Shares Out (Mil) | 3.0 | 41.7 | 10% |
|
| Institutional Ownership | 62.1% | 77.3% | 39% |
|
| Float (Mil) | 2.1 | 34.7 | 5% |
|
| Beta | 0.71 | 0.86 | 41% |
|
| Avg Daily Volume (000s) | 7 | 266 | 15% |
|
| Price Change (52-week) |
(35.8%) | 60.7% | 22% |
|
| Growth | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.8% | 11.8% | 70% |
|
| Net Income (5yr) | 35.7% | (5.8%) | 88% |
|
| EPS (5yr) | 34.6% | 10.7% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (64.9%) | (16.1%) | 3% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $282 | $152 | 35% |
|
| Net Income (TTM) (Mil) | $10 | ($11) | 46% |
|
| EPS (TTM) | $3.359 | ($0.500) | 81% |
|
| Operating Cash Flow (TTM) (Mil) | $19 | ($2) | 41% |
|
| Net Cash Flow (TTM) (Mil) | ($6) | $1 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $47 | $22 | 38% |
|
| Enterprise Value (Q1) (Mil) | $151 | $304 | 24% |
|
| Valuation | KEQU | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.42 | 2.88 | 37% |
|
| P/E | 11.5 | 30.5 | 21% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.3 | 1.9 | 14% |
|
| Ratios | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 28.5% | 59.1% | 33% |
|
| Net Margin | 3.4% | (7.7%) | 43% |
|
| ROA | 5.2% | (13.7%) | 73% |
|
| ROE | 13.8% | (15.9%) | 68% |
|
| Liabilities to Assets | 56.9% | 44.9% | 50% |
|
| F-Score | 5 | 4 | 51% |
|
Kewaunee Scientific Corporation did not pass any screens on 7/30/2026.
